Zobrazeno 1 - 4
of 4
pro vyhledávání: '"G M, Castillo"'
Publikováno v:
Journal of neuroscience research. 62(3)
beta-Amyloid protein (Abeta) is a major component of neuritic plaques and cerebrovascular amyloid deposits in the brains of patients with Alzheimer's disease (AD). Inhibitors of Abeta fibrillogenesis are currently sought as potential future therapeut
Autor:
John Bondo Hansen, Wenhua Yang, G. M. Castillo, A. D. Snow, Malcolm J. Sheardown, J. A. Cummings, Martin Edward Judge, Karin Rimvall
Publikováno v:
Diabetes. 47(4)
Islet amyloidosis is characterized by the deposition and accumulation of amylin in pancreatic beta-cells and is observed in 90% of patients with type 2 diabetes. Previous studies have also revealed the presence of the specific heparan sulfate proteog
Publikováno v:
Journal of neurochemistry. 69(6)
Perlecan is a specific heparan sulfate proteoglycan that accumulates in the fibrillar beta-amyloid (A beta) deposits of Alzheimer's disease. Perlecan purified from the Engelbreth-Holm-Swarm tumor was used to define perlecan's interactions with A beta
Autor:
J D, Miller, J, Cummings, G A, Maresh, D G, Walker, G M, Castillo, C, Ngo, K, Kimata, M G, Kinsella, T N, Wight, A D, Snow
Publikováno v:
Glia. 21(2)
The origin of the heparan sulfate proteoglycan (PG), perlecan, in beta-amyloid protein (A beta)-containing amyloid deposits in Alzheimer's disease (AD) brain is not known. In the present investigation we used indirect immunofluorescence, SDS-PAGE, an